content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001856296</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences LTD.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>7th floor - 50 Broadway</com:street1>
          <com:city>London</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>442074003347</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kumar Rakhi</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza</com:street1>
            <com:street2>Floor 5</com:street2>
            <com:city>New York City</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>227500</noOfUnitsSold>
        <aggregateMarketValue>237296647.00</aggregateMarketValue>
        <noOfUnitsOutstanding>713549458</noOfUnitsOutstanding>
        <approxSaleDate>02/13/2025</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>12/30/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Employee Stock Purchase Plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>4589</amountOfSecuritiesAcquired>
        <paymentDate>12/30/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>06/30/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Employee Stock Purchase Plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>3496</amountOfSecuritiesAcquired>
        <paymentDate>06/30/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>06/28/2024</acquiredDate>
        <natureOfAcquisitionTransaction>Employee Stock Purchase Plan</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>2202</amountOfSecuritiesAcquired>
        <paymentDate>06/28/2024</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>05/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>11026</amountOfSecuritiesAcquired>
        <paymentDate>05/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>03/22/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>4492</amountOfSecuritiesAcquired>
        <paymentDate>03/22/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>03/02/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>2279</amountOfSecuritiesAcquired>
        <paymentDate>03/02/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>05/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>935</amountOfSecuritiesAcquired>
        <paymentDate>05/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>04/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>922</amountOfSecuritiesAcquired>
        <paymentDate>04/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>06/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>922</amountOfSecuritiesAcquired>
        <paymentDate>06/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>10/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>918</amountOfSecuritiesAcquired>
        <paymentDate>10/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>11/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>917</amountOfSecuritiesAcquired>
        <paymentDate>11/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>12/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>916</amountOfSecuritiesAcquired>
        <paymentDate>12/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>12/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>914</amountOfSecuritiesAcquired>
        <paymentDate>12/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common	</securitiesClassTitle>
        <acquiredDate>08/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>910</amountOfSecuritiesAcquired>
        <paymentDate>08/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>07/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>898</amountOfSecuritiesAcquired>
        <paymentDate>07/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>09/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>891</amountOfSecuritiesAcquired>
        <paymentDate>09/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common	</securitiesClassTitle>
        <acquiredDate>06/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>889</amountOfSecuritiesAcquired>
        <paymentDate>06/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>11/20/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>883</amountOfSecuritiesAcquired>
        <paymentDate>11/20/2023</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>08/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>879</amountOfSecuritiesAcquired>
        <paymentDate>08/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>07/20/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Restricted Stock Unit</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>122</amountOfSecuritiesAcquired>
        <paymentDate>07/20/2022</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>02/13/2025</acquiredDate>
        <natureOfAcquisitionTransaction>Stock Option Excercise</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>187500</amountOfSecuritiesAcquired>
        <paymentDate>02/13/2025</paymentDate>
        <natureOfPayment>wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Rakhi Kumar</name>
          <address>
            <com:street1>7th Floor - 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>01/20/2025</saleDate>
        <amountOfSecuritiesSold>1057</amountOfSecuritiesSold>
        <grossProceeds>11785.55</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name> Rakhi Kumar</name>
          <address>
            <com:street1>7th Floor - 50 Broadway,</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>12/20/2024</saleDate>
        <amountOfSecuritiesSold>3087</amountOfSecuritiesSold>
        <grossProceeds>35716.59</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name> Rakhi Kumar</name>
          <address>
            <com:street1>7th Floor - 50 Broadway</com:street1>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <saleDate>11/20/2024</saleDate>
        <amountOfSecuritiesSold>958</amountOfSecuritiesSold>
        <grossProceeds>11007.42</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>02/13/2025</noticeDate>
        <signature>Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Jason Coleman</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 15453}]
text: 144
  0001856296
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences LTD.
  001-40782
  7th floor - 50 Broadway
  London
  X0
  SW1H 0DB
  442074003347
  Kumar Rakhi
  Officer
  Common
  Rockefeller Financial LLC
  45 Rockefeller Plaza
  Floor 5
  New York City
  NY
  10111
  227500
  237296647.00
  713549458
  02/13/2025
  NASDAQ
  Common
  12/30/2022
  Employee Stock Purchase Plan
  Roivant Sciences Ltd
  N
  4589
  12/30/2022
  N/A
  Common
  06/30/2023
  Employee Stock Purchase Plan
  Roivant Sciences Ltd
  N
  3496
  06/30/2023
  N/A
  Common
  06/28/2024
  Employee Stock Purchase Plan
  Roivant Sciences Ltd
  N
  2202
  06/28/2024
  N/A
  Common
  05/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  11026
  05/20/2022
  N/A
  Common
  03/22/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  4492
  03/22/2022
  N/A
  Common
  03/02/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  2279
  03/02/2022
  N/A
  Common
  05/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  935
  05/20/2023
  N/A
  Common
  04/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  922
  04/20/2023
  N/A
  Common
  06/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  922
  06/20/2023
  N/A
  Common
  10/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  918
  10/20/2022
  N/A
  Common
  11/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  917
  11/20/2022
  N/A
  Common
  12/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  916
  12/20/2023
  N/A
  Common
  12/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  914
  12/20/2022
  N/A
  Common
  08/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  910
  08/20/2023
  N/A
  Common
  07/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  898
  07/20/2023
  N/A
  Common
  09/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  891
  09/20/2023
  N/A
  Common
  06/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  889
  06/20/2022
  N/A
  Common
  11/20/2023
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  883
  11/20/2023
  N/A
  Common
  08/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  879
  08/20/2022
  N/A
  Common
  07/20/2022
  Restricted Stock Unit
  Roivant Sciences Ltd
  N
  122
  07/20/2022
  N/A
  Common
  02/13/2025
  Stock Option Excercise
  Roivant Sciences Ltd
  N
  187500
  02/13/2025
  wire
  N
  Rakhi Kumar
  7th Floor - 50 Broadway
  London
  X0
  SW1H 0DB
  Common
  01/20/2025
  1057
  11785.55
  Rakhi Kumar
  7th Floor - 50 Broadway,
  London
  X0
  SW1H 0DB
  Common
  12/20/2024
  3087
  35716.59
  Rakhi Kumar
  7th Floor - 50 Broadway
  London
  X0
  SW1H 0DB
  Common
  11/20/2024
  958
  11007.42
  02/13/2025
  Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Jason Coleman